Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.61 |
| ▸ | CA12 | O43570 | 4/20 | 0.61 |
| ▸ | CA9 | Q16790 | 4/20 | 0.61 |
| ▸ | MAOA | P21397 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30043665 | 1.00 | CA1 (0.61) | CA1CA12CA9MAOANPC1 | |
| SCHEMBL8677800 | 0.93 | MAOA (0.65) | CA1CA12CA9MAOANPC1 | |
| SCHEMBL12909293 | 0.93 | CA12 (0.55) | CA1CA12CA9MAOANPC1 | |
| SCHEMBL1884168 | 0.83 | CA12 (0.53) | CA1CA12CA9MAOANPC1 | |
| SCHEMBL1885693 | 0.83 | CA12 (0.53) | CA1CA12CA9MAOANPC1 | |
| SCHEMBL29853363 | 0.83 | MAPT (0.63) | CA1CA12CA9NPC1RAB9A | |
| SCHEMBL26781086 | 0.83 | MAPT (0.63) | CA1CA12CA9NPC1RAB9A | |
| SCHEMBL4712795 | 0.82 | ALDH1A1 (0.64) | CA1CA12CA9MAOANPC1 | |
| SCHEMBL21113351 | 0.80 | CA12 (0.43) | CA1CA12CA9MAOANPC1 | |
| SCHEMBL30507514 | 0.80 | CA12 (0.53) | CA1CA12CA9MAOARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4328586-A1 | FLUORESCENT STAINING METHOD | OSAKA UNIVERSITY (JP) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023132337-A1 | FLUORESCENT STAINING METHOD | 国立大学法人大阪大学 | 2023-07-13 | — | — | WO | disclosed |
| US-20230152226-A1 | OPTICAL SENSORS | LUMIRADX UK LTD (GB) | 2023-05-18 | — | — | US | disclosed |
| US-20230152226-A1 | OPTICAL SENSORS | LUMIRADX UK LTD (GB) | 2023-05-18 | — | — | US | disclosed |
| EP-4121744-A1 | OPTICAL SENSORS FOR DETECTING THE PRESENCE OR AMOUNT OF A TARGET PRESENT IN A SAMPLE | LUMIRADX UK LTD (GB) | 2023-01-25 | — | — | EP | disclosed |
| US-11519014-B2 | Specific substrate of an ALDH isoenzyme | ADVANCED BIODESIGN (FR) | 2022-12-06 | — | — | US | disclosed |
| WO-2021189057-A1 | OPTICAL SENSORS FOR DETECTING THE PRESENCE OR AMOUNT OF A TARGET PRESENT IN A SAMPLE | LUMIRADX UK LTD. (GB) | 2021-09-23 | — | — | WO | disclosed |
| US-20210072241-A1 | FLUORESCENT PROBE FOR DETECTING CARBOXYPEPTIDASE ACTIVITY | THE UNIVERSITY OF TOKYO (JP) | 2021-03-11 | — | — | US | disclosed |
| US-20190233871-A1 | SPECIFIC SUBSTRATE OF AN ALDH ISOENZYME | ADVANCED BIODESIGN (FR) | 2019-08-01 | — | — | US | disclosed |
| US-20180305329-A1 | XANTHINE COMPOUND AND USE THEREOF | GORYO CHEMICAL, INC. (JP) | 2018-10-25 | — | — | US | disclosed |
| US-7868147-B2 | substantially no fluorescent before the cleavage but highly fluorescent after the cleavage; traps a target substance such as an enzyme and emits fluorescence | Nagano, Tetsuo (JP) | 2011-01-11 | — | — | US | disclosed |
| US-20090317914-A1 | FLUORESCENT PROBE | THE UNIVERSITY OF TOKYO (JP) | 2009-12-24 | — | — | US | disclosed |
| US-7524974-B2 | Fluorescent probe | Nagano, Tetsuo (JP) | 2009-04-28 | — | — | US | disclosed |
| WO-2008075955-A2 | PROCESS FOR THE PREPARATION OF 1,4,5-TRISUBSTITUTED TRIAZOLES AND 3,4,5-TRISUBSTITUTED TRIAZOLES | STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) | 2008-06-26 | — | — | WO | disclosed |
| US-20080014602-A1 | Fluorescent Probe | SEKISUI MEDICAL CO., LTD. (JP) | 2008-01-17 | — | — | US | disclosed |
| US-20080014602-A1 | Fluorescent Probe | SEKISUI MEDICAL CO., LTD. (JP) | 2008-01-17 | — | — | US | disclosed |
| EP-1674579-A1 | FLUORESCENT PROBE | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 2006-06-28 | — | — | EP | disclosed |
| EP-0314480-B1 | Fluorescent indicator dyes for calcium working at long wavelengths | UNIV CALIFORNIA (US) | 1994-09-14 | — | — | EP | disclosed |
| US-5049673-A | Fluorescent indicator dyes for calcium working at long wavelengths | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-09-17 | — | — | US | disclosed |
| EP-0314480-A2 | Fluorescent indicator dyes for calcium working at long wavelengths | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1989-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090317914-A1 | FLUORESCENT PROBE | H1-10, H1-0, NHERF1 | CA1 799/4885CA12 2001/4885CA9 679/4885 |
| US-20210072241-A1 | FLUORESCENT PROBE FOR DETECTING CARBOXYPEPTIDASE ACTIVITY | CPN1, DNPEP, ANPEP | CA1 160/4885CA12 72/4885CA9 111/4885 |
| US-20180305329-A1 | XANTHINE COMPOUND AND USE THEREOF | CYP3A43, CYP3A4, CYP1A1 | CA1 821/4885CA12 1985/4885CA9 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.